Levin Capital Strategies’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
19,000
-24,000
| -56% | -$226K | 0.02% | 162 |
|
|
2025
Q1 | $233K | Sell |
43,000
-11,000
| -20% | -$59.6K | 0.02% | 143 |
|
|
2024
Q4 | $402K | Buy |
54,000
+44,000
| +440% | +$328K | 0.04% | 134 |
|
|
2024
Q3 | $79.9K | Buy |
+10,000
| New | +$79.9K | 0.01% | 193 |
|
|
2023
Q4 | – | Sell |
-20,000
| Closed | -$160K | – | 235 |
|
|
2023
Q3 | $160K | Sell |
20,000
-500
| -2% | -$4K | 0.02% | 201 |
|
|
2023
Q2 | $178K | Sell |
20,500
-58,500
| -74% | -$509K | 0.02% | 202 |
|
|
2023
Q1 | $232K | Hold |
79,000
| – | – | 0.03% | 176 |
|
|
2022
Q4 | $277K | Buy |
+79,000
| New | +$277K | 0.04% | 156 |
|